TZ was subsequently shown to confer significant protection in numerous models of PD (mouse, rat, Drosophila, and human induced pluripotent stem cells) (11), implying that contrary to expectations, PGK1 activity is a critical modulator of glycolytic throughput. The gene discussed is PGK1; the disease is Parkinson disease.